Avalglucosidase Alfa
Generic Name: avalglucosidase alfa
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Active ingredients: AVALGLUCOSIDASE ALFA (100 mg/10mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Active ingredients: AVALGLUCOSIDASE ALFA (100 mg/10mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, powder, lyophilized, for solution.
Related Medications
Bevacizumab-awwb
bevacizumab-awwb
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Bevacizumab-awwb is a vascular endothelial growth factor inhibitor. Bevacizumab-awwb is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-awwb has an approximate molecular weight of 149 kDa. Bevacizumab-awwb is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Ertapenem Sodium
ertapenem sodium
Carbapenem antibiotic indicated for treatment of moderate to severe infections including intra-abdominal, skin, respiratory, urinary tract, and pelvic infections, and surgical prophylaxis.
Clonidine Base
clonidine base
Dosage form: POWDER. Active ingredients: CLONIDINE (1 kg/kg). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.